• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征对心血管风险的长期影响。

Long-term consequences of polycystic ovary syndrome on cardiovascular risk.

作者信息

Rizzo Manfredi, Berneis Kaspar, Spinas Giatgen, Rini Giovam Battista, Carmina Enrico

机构信息

Department of Internal Medicine and Emerging Diseases, University of Palermo, Palermo, Italy.

出版信息

Fertil Steril. 2009 Apr;91(4 Suppl):1563-7. doi: 10.1016/j.fertnstert.2008.09.070. Epub 2008 Oct 30.

DOI:10.1016/j.fertnstert.2008.09.070
PMID:18976752
Abstract

Most available data suggest that the prevalence of cardiovascular diseases in women with polycystic ovary syndrome (PCOS) is smaller than expected based on risk calculations during fertile years; therefore, more studies are needed on long-term cardiovascular consequences. Evidence is accumulating that postmenopausal women with PCOS have an increased risk of cerebrovascular events and cardiovascular morbidity. These events are partially related to persisting hyperandrogenism but are mostly correlated with excessive body weight (mainly visceral obesity); this suggests that our best long-term strategy is to ensure that women with PCOS are informed about their high risk for metabolic and cardiovascular diseases.

摘要

大多数现有数据表明,多囊卵巢综合征(PCOS)女性心血管疾病的患病率低于根据生育期风险计算预期的水平;因此,需要更多关于长期心血管后果的研究。越来越多的证据表明,绝经后PCOS女性发生脑血管事件和心血管疾病的风险增加。这些事件部分与持续的高雄激素血症有关,但大多与体重超标(主要是内脏肥胖)相关;这表明我们最佳的长期策略是确保让PCOS女性了解她们患代谢和心血管疾病的高风险。

相似文献

1
Long-term consequences of polycystic ovary syndrome on cardiovascular risk.多囊卵巢综合征对心血管风险的长期影响。
Fertil Steril. 2009 Apr;91(4 Suppl):1563-7. doi: 10.1016/j.fertnstert.2008.09.070. Epub 2008 Oct 30.
2
Obesity and the polycystic ovary syndrome.肥胖与多囊卵巢综合征
Minerva Endocrinol. 2007 Sep;32(3):129-40.
3
Androgen excess and cardiovascular risk.雄激素过多与心血管风险。
Minerva Endocrinol. 2007 Mar;32(1):67-71.
4
Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.多囊卵巢综合征女性患心血管疾病的风险是否增加?证据综述。
Minerva Ginecol. 2004 Feb;56(1):27-39.
5
Metabolic and cardiovascular consequences of polycystic ovary syndrome.多囊卵巢综合征的代谢及心血管后果
Minerva Ginecol. 2008 Feb;60(1):39-51.
6
Cardiovascular disease risk factors in polycystic ovary syndrome.多囊卵巢综合征中的心血管疾病风险因素。
Semin Reprod Med. 2008 Jan;26(1):39-44. doi: 10.1055/s-2007-992923.
7
Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.多囊卵巢综合征:女性高雄激素血症最常见的病因,作为代谢综合征的一个危险因素。
Minerva Endocrinol. 2007 Mar;32(1):35-47.
8
Pathophysiology and types of dyslipidemia in PCOS.多囊卵巢综合征中血脂异常的病理生理学及类型
Trends Endocrinol Metab. 2007 Sep;18(7):280-5. doi: 10.1016/j.tem.2007.07.004. Epub 2007 Aug 10.
9
Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?多囊卵巢综合征女性心血管风险特征分析:是否不止各部分之和?
Semin Reprod Med. 2009 Jul;27(4):299-305. doi: 10.1055/s-0029-1225257. Epub 2009 Jun 15.
10
Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.多囊卵巢综合征绝经后妇女的心血管风险。
Maturitas. 2011 Jan;68(1):13-6. doi: 10.1016/j.maturitas.2010.09.005. Epub 2010 Oct 12.

引用本文的文献

1
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.《柳叶刀》冠心病重新思考委员会:从缺血到动脉粥样硬化的转变
Lancet. 2025 Apr 12;405(10486):1264-1312. doi: 10.1016/S0140-6736(25)00055-8. Epub 2025 Mar 31.
2
Oral and Vaginal Hormonal Contraceptives Induce Similar Unfavorable Metabolic Effects in Women with PCOS: A Randomized Controlled Trial.口服和阴道激素避孕药对多囊卵巢综合征女性产生相似的不良代谢影响:一项随机对照试验。
J Clin Med. 2023 Apr 12;12(8):2827. doi: 10.3390/jcm12082827.
3
Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.
代谢综合征发病年龄与心血管疾病的关系:开滦研究。
Front Endocrinol (Lausanne). 2022 Mar 17;13:857985. doi: 10.3389/fendo.2022.857985. eCollection 2022.
4
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS.多囊卵巢综合征女性心血管代谢风险控制的药物治疗方法。
Int J Mol Sci. 2020 Dec 15;21(24):9554. doi: 10.3390/ijms21249554.
5
Changes in Metabolic Profile in the Women with a History of PCOS-A Long-Term Follow-Up Study.多囊卵巢综合征病史女性代谢谱的变化——一项长期随访研究
J Clin Med. 2020 Oct 20;9(10):3367. doi: 10.3390/jcm9103367.
6
Circulating SCUBE1 levels in women with polycystic ovary syndrome.多囊卵巢综合征女性的循环SCUBE1水平
Turk J Obstet Gynecol. 2018 Sep;15(3):152-158. doi: 10.4274/tjod.25826. Epub 2018 Sep 3.
7
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.脂质组学揭示甘油磷脂生物合成途径和细胞信号转导的改变作为多囊卵巢综合征的生物标志物。
Oncotarget. 2017 Dec 17;9(4):4522-4536. doi: 10.18632/oncotarget.23393. eCollection 2018 Jan 12.
8
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.肌醇对多囊卵巢综合征女性的影响:一项随机对照试验的荟萃分析。
Endocr Connect. 2017 Nov;6(8):647-658. doi: 10.1530/EC-17-0243.
9
..
Physiology (Bethesda). 2017 Sep;32(5):357-366. doi: 10.1152/physiol.00030.2016.
10
Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention.重视妇产科医生在心血管疾病预防中的作用。
Curr Opin Cardiol. 2013 Sep;28(5):547-53. doi: 10.1097/HCO.0b013e328364298e.